RFPi offers a ground-floor opportunity for investors to be part of bringing a breakthrough technology to market. Learn more about our market opportunities and how you can become a partner.
The ability to visualize and understand the vascular integrity of tissues is previously unavailable information in real time during procedures. See how our iCertainty non-invasive technology can quantify the physiology of blood flow and perfusion where knowledge of that information could improve outcomes.
An improvement in technical outcomes may result in fewer complications, shorter hospital stays and reduced readmissions. Translation: the possibility of overall reduced health system costs and enhanced patient care.
January 9, 2018 – RFPi Invited to Present at Biotech Showcase 2018
SAGES - Society of American Gastrointestinal and Endoscopic Surgeons - April 3-4, Baltimore, MD RFPi Chief Medical Officer, Bruce Ferguson, MD and CEO Jeff Basham will be attending SAGES meeting in Baltimore. Dr. Ferguson has had an RFPi poster accepted and will present at the SAGES i3 Summit, “Bringing innovators, investors, and industry together to foster innovative and emerging technologies that benefit patients.”
J.P.Morgan Healthcare Conference January 7-10, 2019